c15-160: Enzalutamide (ENZA) plus CC-115 in men with metastatic castration-resistant prostate cancer (mCRPC): A phase 1b Prostate Cancer Clinical Trials Consortium study.

Dana E. Rathkopf; Karen A. Autio; Emmanuel S. Antonarakis; Heather H. Cheng; Gabrielle Arauz; Annelise Slack; Melanie Hullings; Howard I. Scher; Felix Y Feng; Karen E. Knudsen

doi:10.1200/jco.2018.36.15_suppl.5045

c15-160: Enzalutamide (ENZA) plus CC-115 in men with metastatic castration-resistant prostate cancer (mCRPC): A phase 1b Prostate Cancer Clinical Trials Consortium study.

Journal of Clinical Oncology ◽

10.1200/jco.2018.36.15_suppl.5045 ◽

2018 ◽

Vol 36 (15_suppl) ◽

pp. 5045-5045

Author(s):

Dana E. Rathkopf ◽

Karen A. Autio ◽

Emmanuel S. Antonarakis ◽

Heather H. Cheng ◽

Gabrielle Arauz ◽

...

Keyword(s):

Prostate Cancer ◽

Clinical Trials ◽

Cancer Clinical Trials ◽

Castration Resistant Prostate Cancer ◽

Castration Resistant ◽

Phase 1B

Download Full-text

c15-149: A phase 1b study of the oral CDK4/6 inhibitor ribociclib in combination with docetaxel plus prednisone in metastatic castration resistant prostate cancer (mCRPC)—A prostate cancer clinical trials consortium study.

Journal of Clinical Oncology ◽

10.1200/jco.2018.36.15_suppl.e17028 ◽

2018 ◽

Vol 36 (15_suppl) ◽

pp. e17028-e17028 ◽

Cited By ~ 1

Author(s):

Catriona Lewis ◽

David C. Smith ◽

Benedito A. Carneiro ◽

Charles J. Ryan ◽

Tammy J. Rodvelt ◽

...

Keyword(s):

Prostate Cancer ◽

Clinical Trials ◽

Cancer Clinical Trials ◽

Castration Resistant Prostate Cancer ◽

Castration Resistant ◽

Phase 1B

Download Full-text

Intermittent Chemotherapy as a Platform for Testing Novel Agents in Patients With Metastatic Castration-Resistant Prostate Cancer: A Department of Defense Prostate Cancer Clinical Trials Consortium Randomized Phase II Trial of Intermittent Docetaxel With Prednisone With or Without Maintenance GM-CSF

Clinical Genitourinary Cancer ◽

10.1016/j.clgc.2014.12.004 ◽

2015 ◽

Vol 13 (3) ◽

pp. e191-e198 ◽

Cited By ~ 5

Author(s):

Rahul R. Aggarwal ◽

Tomasz M. Beer ◽

Vivian K. Weinberg ◽

Celestia Higano ◽

Mary-Ellen Taplin ◽

...

Keyword(s):

Prostate Cancer ◽

Clinical Trials ◽

Department Of Defense ◽

Phase Ii Trial ◽

Cancer Clinical Trials ◽

Castration Resistant Prostate Cancer ◽

Gm Csf ◽

Castration Resistant ◽

Randomized Phase Ii ◽

Intermittent Chemotherapy

Download Full-text

Correlation between Imaging-based Intermediate Endpoints and Overall Survival in Men with Metastatic Castration-Resistant Prostate Cancer: Analysis of 28 Randomized Trials using the Prostate Cancer Clinical Trials Working Group (PCWG2) criteria in 16,511 patients

Clinical Genitourinary Cancer ◽

10.1016/j.clgc.2021.11.007 ◽

2021 ◽

Author(s):

Sungmin Woo ◽

Chong Hyun Suh ◽

Andreas G. Wibmer ◽

Anton S. Becker ◽

Min Yuen Teo ◽

...

Keyword(s):

Prostate Cancer ◽

Overall Survival ◽

Clinical Trials ◽

Working Group ◽

Randomized Trials ◽

Cancer Clinical Trials ◽

Castration Resistant Prostate Cancer ◽

Castration Resistant

Download Full-text

Activity of abiraterone acetate (AA) in metastatic castration-resistant prostate cancer (mCRPC) patients (pts) previously treated with ketoconazole (keto): A prospective phase II study from the Prostate Cancer Clinical Trials Consortium.

Journal of Clinical Oncology ◽

10.1200/jco.2014.32.15_suppl.5039 ◽

2014 ◽

Vol 32 (15_suppl) ◽

pp. 5039-5039 ◽

Cited By ~ 1

Author(s):

Won Kim ◽

John Wilton ◽

Li Zhang ◽

Amy M. Lin ◽

Lawrence Fong ◽

...

Keyword(s):

Prostate Cancer ◽

Clinical Trials ◽

Phase Ii ◽

Phase Ii Study ◽

Abiraterone Acetate ◽

Cancer Clinical Trials ◽

Castration Resistant Prostate Cancer ◽

Castration Resistant ◽

Prospective Phase ◽

Previously Treated

Download Full-text

Saracatinib as a metastasis inhibitor in metastatic castration-resistant prostate cancer: A University of Chicago Phase 2 Consortium and DOD/PCF Prostate Cancer Clinical Trials Consortium Study

The Prostate ◽

10.1002/pros.23119 ◽

2015 ◽

Vol 76 (3) ◽

pp. 286-293 ◽

Cited By ~ 15

Author(s):

Edwin M. Posadas ◽

Rafi S. Ahmed ◽

Theodore Karrison ◽

Russell Z. Szmulewitz ◽

Peter H. O'Donnell ◽

...

Keyword(s):

Prostate Cancer ◽

Clinical Trials ◽

Cancer Clinical Trials ◽

Phase 2 ◽

University Of Chicago ◽

Castration Resistant Prostate Cancer ◽

Castration Resistant ◽

Metastasis Inhibitor

Download Full-text

Cilengitide (EMD 121974, NSC 707544) in asymptomatic metastatic castration resistant prostate cancer patients: a randomized phase II trial by the prostate cancer clinical trials consortium

Investigational New Drugs ◽

10.1007/s10637-010-9420-8 ◽

2010 ◽

Vol 29 (6) ◽

pp. 1432-1440 ◽

Cited By ~ 34

Author(s):

Deborah A. Bradley ◽

Stephanie Daignault ◽

Charles J. Ryan ◽

Robert S. DiPaola ◽

David C. Smith ◽

...

Keyword(s):

Prostate Cancer ◽

Clinical Trials ◽

Cancer Patients ◽

Phase Ii ◽

Phase Ii Trial ◽

Cancer Clinical Trials ◽

Castration Resistant Prostate Cancer ◽

Castration Resistant ◽

Randomized Phase Ii

Download Full-text

Bone scan “flare” in patients receiving abiraterone acetate (AA) for metastatic castration resistant prostate cancer (mCRPC): Analysis of data from a phase II study of the Department of Defense Prostate Cancer Clinical Trials Consortium.

Journal of Clinical Oncology ◽

10.1200/jco.2010.28.15_suppl.4545 ◽

2010 ◽

Vol 28 (15_suppl) ◽

pp. 4545-4545 ◽

Cited By ~ 1

Author(s):

S. K. Shah ◽

C. J. Ryan ◽

C. Kilian ◽

A. Hubbell ◽

T. S. Kheoh ◽

...

Keyword(s):

Prostate Cancer ◽

Clinical Trials ◽

Phase Ii ◽

Department Of Defense ◽

Bone Scan ◽

Phase Ii Study ◽

Abiraterone Acetate ◽

Cancer Clinical Trials ◽

Castration Resistant Prostate Cancer ◽

Castration Resistant

Download Full-text

Intermittent chemotherapy (ICh) for metastatic castration-resistant prostate cancer (mCRPC): Results of a prospective randomized phase II trial of the DoD Prostate Cancer Clinical Trials Consortium.

Journal of Clinical Oncology ◽

10.1200/jco.2010.28.15_suppl.4684 ◽

2010 ◽

Vol 28 (15_suppl) ◽

pp. 4684-4684

Author(s):

E. J. Small ◽

T. M. Beer ◽

V. K. Weinberg ◽

C. S. Higano ◽

L. T. Nordquist ◽

...

Keyword(s):

Prostate Cancer ◽

Clinical Trials ◽

Phase Ii ◽

Phase Ii Trial ◽

Cancer Clinical Trials ◽

Castration Resistant Prostate Cancer ◽

Castration Resistant ◽

Randomized Phase Ii ◽

Intermittent Chemotherapy

Download Full-text

Abiraterone acetate (AA) in patients with metastatic castration-resistant prostate cancer (mCRPC) and prior therapy with ketoconazole: A Prostate Cancer Clinical Trials Consortium study.

Journal of Clinical Oncology ◽

10.1200/jco.2011.29.15_suppl.4500 ◽

2011 ◽

Vol 29 (15_suppl) ◽

pp. 4500-4500 ◽

Cited By ~ 2

Author(s):

C. J. Ryan ◽

A. L. Harzstark ◽

A. M. Lin ◽

L. Fong ◽

K. Grycz ◽

...

Keyword(s):

Prostate Cancer ◽

Clinical Trials ◽

Abiraterone Acetate ◽

Cancer Clinical Trials ◽

Castration Resistant Prostate Cancer ◽

Prior Therapy ◽

Castration Resistant

Download Full-text

Second-Line Cabazitaxel Treatment in Castration-Resistant Prostate Cancer Clinical Trials Compared to Standard of Care in CAPRI: Observational Study in the Netherlands

Clinical Genitourinary Cancer ◽

10.1016/j.clgc.2019.05.018 ◽

2019 ◽

Vol 17 (5) ◽

pp. e946-e956

Author(s):

Hans M. Westgeest ◽

Malou C.P. Kuppen ◽

Alphonsus J.M. van den Eertwegh ◽

Ronald de Wit ◽

Juleon L.L.M. Coenen ◽

...

Keyword(s):

Prostate Cancer ◽

Clinical Trials ◽

The Netherlands ◽

Observational Study ◽

Standard Of Care ◽

Cancer Clinical Trials ◽

Second Line ◽

Castration Resistant Prostate Cancer ◽

Castration Resistant

Download Full-text